A citation-based method for searching scientific literature

P Madadi, C J D Ross, M R Hayden, B C Carleton, A Gaedigk, J S Leeder, G Koren. Clin Pharmacol Ther 2009
Times Cited: 182







List of co-cited articles
921 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.
Gideon Koren, James Cairns, David Chitayat, Andrea Gaedigk, Steven J Leeder. Lancet 2006
384
56

Codeine intoxication associated with ultrarapid CYP2D6 metabolism.
Yvan Gasche, Youssef Daali, Marc Fathi, Alberto Chiappe, Silvia Cottini, Pierre Dayer, Jules Desmeules. N Engl J Med 2004
405
31

Codeine, ultrarapid-metabolism genotype, and postoperative death.
Catherine Ciszkowski, Parvaz Madadi, Michael S Phillips, Albert E Lauwers, Gideon Koren. N Engl J Med 2009
219
24

More codeine fatalities after tonsillectomy in North American children.
Lauren E Kelly, Michael Rieder, John van den Anker, Becky Malkin, Colin Ross, Michael N Neely, Bruce Carleton, Michael R Hayden, Parvaz Madadi, Gideon Koren. Pediatrics 2012
233
23

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014
368
22

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.
K R Crews, A Gaedigk, H M Dunnenberger, T E Klein, D D Shen, J T Callaghan, E D Kharasch, T C Skaar. Clin Pharmacol Ther 2012
248
21

Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia.
Jessica Lam, Lauren Kelly, Catherine Ciszkowski, Marieke L A Landsmeer, Marieke Nauta, Bruce C Carleton, Michael R Hayden, Parvaz Madadi, Gideon Koren. J Pediatr 2012
61
32

Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
J Kirchheiner, H Schmidt, M Tzvetkov, J-T H A Keulen, J Lötsch, I Roots, J Brockmöller. Pharmacogenomics J 2007
246
18

Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study.
S Willmann, A N Edginton, K Coboeken, G Ahr, J Lippert. Clin Pharmacol Ther 2009
82
19

Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine.
Parvaz Madadi, Gideon Koren, James Cairns, David Chitayat, Andrea Gaedigk, J Steven Leeder, Ronni Teitelbaum, Tatyana Karaskov, Katarina Aleksa. Can Fam Physician 2007
100
16

Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.
J Sistonen, P Madadi, C J Ross, M Yazdanpanah, J W Lee, M L A Landsmeer, M Nauta, B C Carleton, G Koren, M R Hayden. Clin Pharmacol Ther 2012
43
37

Uniform assessment and ranking of opioid μ receptor binding constants for selected opioid drugs.
Donna A Volpe, Grainne A McMahon Tobin, R Daniel Mellon, Aspandiar G Katki, Robert J Parker, Thomas Colatsky, Timothy J Kropp, S Leigh Verbois. Regul Toxicol Pharmacol 2011
184
15

Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer.
Polina Voronov, Henry J Przybylo, Narasimhan Jagannathan. Paediatr Anaesth 2007
100
15

Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.
Ulrike M Stamer, Frank Stüber, Thomas Muders, Frank Musshoff. Anesth Analg 2008
96
14

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
574
13

Impact of CYP2D6 genotype on postoperative tramadol analgesia.
Ulrike M Stamer, Katja Lehnen, Fabienne Höthker, Bettina Bayerer, Stephanie Wolf, Andreas Hoeft, Frank Stuber. Pain 2003
189
13

Guidelines for maternal codeine use during breastfeeding.
Parvaz Madadi, Myla Moretti, Nada Djokanovic, Pina Bozzo, Irena Nulman, Shinya Ito, Gideon Koren. Can Fam Physician 2009
41
29

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety.
C F Samer, Y Daali, M Wagner, G Hopfgartner, C B Eap, M C Rebsamen, M F Rossier, D Hochstrasser, P Dayer, J A Desmeules. Br J Pharmacol 2010
112
11

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.
Trine Naalsund Andreassen, Ingrid Eftedal, Pål Klepstad, Andrew Davies, Kristin Bjordal, Staffan Lundström, Stein Kaasa, Ola Dale. Eur J Clin Pharmacol 2012
65
16


Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
U M Stamer, F Musshoff, M Kobilay, B Madea, A Hoeft, F Stuber. Clin Pharmacol Ther 2007
150
11


The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.
C F Samer, Y Daali, M Wagner, G Hopfgartner, C B Eap, M C Rebsamen, M F Rossier, D Hochstrasser, P Dayer, J A Desmeules. Br J Pharmacol 2010
100
10

Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.
Julia Kirchheiner, Jan-Tobias H A Keulen, Steffen Bauer, Ivar Roots, Jürgen Brockmöller. J Clin Psychopharmacol 2008
113
10

CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
Sondra VanderVaart, Howard Berger, Johanna Sistonen, Parvaz Madadi, Ilan Matok, Violette M G J Gijsen, Saskia N de Wildt, Anna Taddio, Colin J D Ross, Bruce C Carleton,[...]. Ther Drug Monit 2011
30
33


Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication.
S Ito, A Blajchman, M Stephenson, C Eliopoulos, G Koren. Am J Obstet Gynecol 1993
113
9

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.
Bojan Lalovic, Evan Kharasch, Christine Hoffer, Linda Risler, Lee-Yuan Liu-Chen, Danny D Shen. Clin Pharmacol Ther 2006
280
9

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
Trude Teoline Rakvåg, Pål Klepstad, Cecilie Baar, Tor-Morten Kvam, Ola Dale, Stein Kaasa, Hans Einar Krokan, Frank Skorpen. Pain 2005
230
9


The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
A Gaedigk, S D Simon, R E Pearce, L D Bradford, M J Kennedy, J S Leeder. Clin Pharmacol Ther 2008
478
9

Codeine and morphine pathway.
Caroline F Thorn, Teri E Klein, Russ B Altman. Pharmacogenet Genomics 2009
53
16

Establishing causality of CNS depression in breastfed infants following maternal codeine use.
Parvaz Madadi, Farshad Shirazi, Frank G Walter, Gideon Koren. Paediatr Drugs 2008
29
27

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.
Parvaz Madadi, Doris Hildebrandt, Inna Y Gong, Ute I Schwarz, Catherine Ciszkowski, Colin J D Ross, Johanna Sistonen, Bruce C Carleton, Michael R Hayden, Albert E Lauwers,[...]. Pediatrics 2010
51
15

Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.
Ken-ichi Fujita, Yuichi Ando, Wataru Yamamoto, Toshimichi Miya, Hisashi Endo, Yu Sunakawa, Kazuhiro Araki, Keiji Kodama, Fumio Nagashima, Wataru Ichikawa,[...]. Cancer Chemother Pharmacol 2010
63
12

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
Cielito C Reyes-Gibby, Sanjay Shete, Trude Rakvåg, Samrat V Bhat, Frank Skorpen, Eduardo Bruera, Stein Kaasa, Pål Klepstad. Pain 2007
212
8

Impact of environmental and genetic factors on codeine analgesia.
J Desmeules, M P Gascon, P Dayer, M Magistris. Eur J Clin Pharmacol 1991
178
8

Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia.
S T Zwisler, T P Enggaard, S Mikkelsen, K Brosen, S H Sindrup. Acta Anaesthesiol Scand 2010
70
11

CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.
Johanna Sistonen, Antti Sajantila, Oscar Lao, Jukka Corander, Guido Barbujani, Silvia Fuselli. Pharmacogenet Genomics 2007
254
8

Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics.
S Sadhasivam, V Chidambaran, X Zhang, J Meller, H Esslinger, K Zhang, L J Martin, J McAuliffe. Pharmacogenomics J 2015
51
15


Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
I Johansson, E Lundqvist, L Bertilsson, M L Dahl, F Sjöqvist, M Ingelman-Sundberg. Proc Natl Acad Sci U S A 1993
536
7

Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief.
D Campa, A Gioia, A Tomei, P Poli, R Barale. Clin Pharmacol Ther 2008
220
7

Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype.
Masakazu Hayashida, Makoto Nagashima, Yasuo Satoh, Ryoji Katoh, Megumi Tagami, Soichiro Ide, Shinya Kasai, Daisuke Nishizawa, Yasukazu Ogai, Junko Hasegawa,[...]. Pharmacogenomics 2008
101
7

The hypoalgesic effect of tramadol in relation to CYP2D6.
L Poulsen, L Arendt-Nielsen, K Brøsen, S H Sindrup. Clin Pharmacol Ther 1996
288
7

Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine.
P Dalén, C Frengell, M L Dahl, F Sjöqvist. Ther Drug Monit 1997
97
7



The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.
Stine T Zwisler, Thomas P Enggaard, Lene Noehr-Jensen, Rasmus S Pedersen, Soeren Mikkelsen, Flemming Nielsen, Kim Brosen, Soeren H Sindrup. Basic Clin Pharmacol Toxicol 2009
70
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.